Repurposed drug shows potential as leukaemia treatment
The drug, originally known as DDD86481 and now named PCLX-001, will be trialled in adult patients with relapsed or refractory…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
clinical trial
Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine
The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as workshops with annual…
Geron’s blood cancer drug succeeds in late-stage study, shares surge
Geron’s drug, imetelstat, was being studied in patients with a type of myelodysplastic syndromes (MDS), a difficult-to-treat…
Pfizer’s hemophilia B gene therapy succeeds in late-stage study
Data from the study showed that a single dose of the therapy was superior to the current standard of care in helping reduce the…
Dr Reddy’s completes phase-I study of proposed biosimilar of Tocilizumab
Tocilizumab is an anti-rheumatic agent used in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis…
AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer
Imfinzi, in a phase-III trial called 'Pearl', failed in patients whose tumour cells express high levels of PD-L1, or in a subgroup…
Biocon starts clinical study to evaluate efficacy of Itolizumab
This is a phase-II randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two-treatment period…
Roche’s Alzheimer’s drug fails to meet goal in long awaited trial
The Swiss drugmaker conducted two identically designed studies, each with about 1,000 participants, who were examined and queried…
AstraZeneca drug fails one main goal in study of chronic immune disease
Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210…
Relmada’s depression drug fails to meet late-stage study goal
Relmada will continue to study REL-1017, its lead treatment, as an adjuntive or in combination with other depression drugs